Vascular Stent Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Vascular stents are small, expandable mesh tubes implanted in blood vessels to restore and maintain adequate blood flow in patients with arterial narrowing or blockage caused by atherosclerosis and other vascular diseases. The market encompasses coronary stents, peripheral vascular stents, and carotid stents, with products ranging from bare-metal stents to drug-eluting and bioresorbable variants. Valued at approximately $15.39 billion in 2025, this market serves a global patient population affected by conditions that impact arteries, veins, and lymphatic vessels throughout the body.

• •Addresses circulatory system diseases affecting blood vessel health and function across arteries, veins, and lymph vessels
• •Encompasses multiple stent types including coronary, peripheral, and carotid applications

The primary growth catalyst is the rising global prevalence of vascular diseases, particularly atherosclerosis, which involves plaque buildup that restricts blood flow and can lead to serious complications if untreated. Demographic trends play a significant role, as aging populations worldwide experience higher rates of cardiovascular and peripheral vascular conditions requiring intervention. Advances in minimally invasive procedures, including improved stent materials and drug-eluting technologies, continue to expand treatment options and patient eligibility.

• •Increasing incidence of peripheral artery disease and coronary artery disease linked to sedentary lifestyles, smoking, and hypertension
• •Technological innovations in drug-eluting stents and bioresorbable scaffolds improving clinical outcomes and reducing restenosis rates
• •Growing preference for minimally invasive surgical procedures over open vascular surgery due to shorter recovery times

The market is segmented by product type into coronary stents, peripheral stents, and other vascular stents, with coronary stents historically representing the largest segment. Material-based segmentation includes metallic stents, polymer-based stents, and bioresorbable stents, each serving distinct clinical needs. Geographically, North America leads in market share due to advanced healthcare infrastructure and high procedure volumes, while Asia-Pacific is the fastest-growing region driven by improving access to care and rising disease burden.

• •North America dominates with advanced healthcare systems and high adoption of premium stent technologies
• •Asia-Pacific emerging as the fastest-growing region due to expanding healthcare access and rising prevalence of lifestyle-related vascular diseases
• •Europe maintains a significant share with strong regulatory frameworks supporting innovative medical device approvals

What are the recent trends and outlook?

The market is moving toward next-generation stent technologies, including fully bioresorbable scaffolds that dissolve after vessel healing and drug-coated balloons that reduce restenosis without permanent implant. Value-based healthcare models are influencing purchasing decisions as payers prioritize clinical outcomes and cost-effectiveness over device novelty alone. The ongoing 3.7% annual growth rate suggests sustained expansion through 2030 and beyond, supported by demographic pressures and continued procedural volume growth in both established and emerging markets.

• •Bioresorbable vascular scaffolds and drug-eluting technologies gaining traction as alternatives to permanent metallic implants
• •Miniaturization and improved deliverability of stents enabling treatment of more complex and previously inaccessible lesions
• •Rising focus on combination therapies and post-procedure pharmacology to optimize long-term vessel health